United Therapeutics (UTHR) Stock Forecast & Price Target
Score
United Therapeutics Corporation price target
| UTHR | |
|---|---|
| Low | $368.00 |
| Average | $674.00 |
| High | $850.00 |
| Upside vs current price | +13.2% |
The average target of $674.00 is +13.2% versus the current UTHR price of $595.66.
United Therapeutics Corporation analyst ratings
| Rating | Analysts |
|---|---|
| Strong buy | 3 |
| Buy | 8 |
| Hold | 3 |
| Sell | 1 |
| Strong sell | 0 |
| Consensus | Buy |
15 analysts cover UTHR.
United Therapeutics Corporation EPS and revenue estimates
Published annual figures for UTHR on this page are 2026 EPS $26.66, 2027 EPS $30.57. Coverage under three analysts is omitted.
| Fiscal year | EPS estimate | Revenue estimate |
|---|---|---|
| 2026 | $26.66 | $3.18B |
| 2027 | $30.57 | $3.55B |
Is United Therapeutics Corporation a buy or sell?
Of the 15 analysts covering United Therapeutics Corporation, 11 rate it a buy (3 strong buy and 8 buy), 3 rate it a hold, and 1 rates it a sell (1 sell and 0 strong sell).
The UTHR consensus label is Buy, beside 11 buy-side ratings and 1 sell-side ratings.
The average target of $674.00 implies +13.2% versus the current price of $595.66.
The UTHR rating block is 15 published views with a Buy label. It does not tell you whether to buy or sell.
Reading the United Therapeutics Corporation forecast
A wide spread is the story on UTHR. Targets run from $368.00 to $850.00, with $674.00 as the average.
The gap from the $595.66 price to the UTHR average is +13.2%.
The UTHR rating mix is lopsided rather than split: 11 of 15 analysts are on the buy side, 3 are at hold, and 1 is on the sell side, and the published consensus is Buy.
The latest UTHR actions do not point one way: 1 up and 0 down.
Month by month, the UTHR average target is higher ($689.13) than the quarterly average ($643.36).
the United Therapeutics Corporation is followed by 15 analysts, so the range matters more than any one target.
United Therapeutics Corporation forecast questions
What is the UTHR price target?
The published range for UTHR is $368.00 to $850.00, with an average of $674.00. That average is +13.2% versus the current price of $595.66.
Is United Therapeutics Corporation a buy or sell?
Of the 15 analysts covering United Therapeutics Corporation, 11 rate it a buy, 3 rate it a hold, and 1 rates it a sell. The consensus is Buy, leaving UTHR at 11 buy ratings, 3 holds, and 1 sells.
What is the EPS estimate for United Therapeutics Corporation?
Analyst EPS estimates for United Therapeutics Corporation: 2026 $26.66, 2027 $30.57.
What is the revenue estimate for United Therapeutics Corporation?
Analyst revenue estimates for United Therapeutics Corporation: 2026 $3.18B, 2027 $3.55B.
How many analysts cover UTHR?
15 analysts cover UTHR. Their consensus on UTHR is Buy, across those 15.